Tysabri drives 48% increase in Biogen Idec's fourth-quarter income
This article was originally published in Scrip
Executive Summary
Biogen Idec reported total revenues in 2009 of $4.4 billion, an increase of 7% on the previous year, driven primarily by its multiple sclerosis franchise.